Announcements Trials

Browse Landscape

Phase

Status

Completed 48 Recruiting 20 Unknown 13 Active not recruiting 10 Not yet recruiting 7 Withdrawn 6 Terminated 6 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cisplatin 9 Specimen Handling 7 Educational Status 7 Standard of Care 6 Interviews as Topic 6 Drug Therapy 6 Carboplatin 6 Blood Specimen Collection 6 Radiotherapy 5 Nivolumab 5 Chemoradiotherapy 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Paclitaxel 4 Oxaliplatin 4 Observation 4 Lenalidomide 4 Fluorouracil 4 Fluorodeoxyglucose F18 4 Dexamethasone 4 pembrolizumab 3 lenvatinib 3 camrelizumab 3 Practice Guidelines as Topic 3 Patient Navigation 3 Methods 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Gemcitabine 3 Exercise 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Tablets × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡